Singapore markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.49+0.40 (+3.31%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts10101112
Avg. Estimate-2.79-2.55-10.48-5.04
Low estimate-3.02-2.97-11.14-9.35
High estimate-2.51-1.64-9.14.73
Year ago EPS-3.07-3.89-5.23-10.48
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts991111
Avg. Estimate16.53M21.91M87.49M207.38M
Low estimate13M16.5M78.14M100M
High estimate21.19M28.89M102.26M546.7M
Year ago salesN/A9.64M227.55M87.49M
Sales growth (year/est)N/A127.30%-61.60%137.00%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS-3.44-3.76-2.52-1.84
Actual EPS-3.07-3.89-3.5-1.67
Difference0.37-0.13-0.980.17
Surprise %10.80%-3.50%-38.90%9.20%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-2.79-2.55-10.48-5.04
7 days ago-2.79-2.55-10.48-5.04
30 days ago-2.76-2.5-10.42-5.06
60 days ago-2.79-2.5-10.58-5.23
90 days ago-2.79-2.5-10.58-5.23
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesESPRIndustrySector(s)S&P 500
Current qtr.9.10%N/AN/AN/A
Next qtr.34.40%N/AN/AN/A
Current year-100.40%N/AN/AN/A
Next year51.90%N/AN/AN/A
Next 5 years (per annum)16.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A